TY  - JOUR
TI  - Evaluation of pain in patients with COVID-19
AB  - Objectives: A new type of coronavirus outbreak has emerged in China and caused a pandemic. World Health Organization (WHO) announced the official name of this disease ‘COVID-19’. The main purpose of this study is to evaluate pain in COVID-19 patients. Methods: Patients who were followed in the ward of an infectious diseases department because of possible or confirmed COVID-19 between May and September of 2020 were included in the study. The Turkish version of the Brief Pain Inventory (BPI) was applied. Demographic features, frequency, location, the intensity of pain, and response to analgesics were analyzed. Results: A total of 178 participants were included in the study. Ninety-one (51.1%) of patients had pain complaints and the mean pain score (MPS) was 2.28±2.81 over 10. Fifty-nine (56.0%) of participants with pain required analgesic therapy and 41 (80.3%) of them showed ≥50% pain relief with simple analgesics. Twelve of the remaining 18 who did not get enough pain relief with simple analgesic were taking their analgesics pro re nata (PRN) rather than around the clock (ATC). Pain frequency and intensity and mean hospitalization duration (MHD) were similar between confirmed and possible cases. Conclusion: Regarding the results, we conclude that pain is not one of the challenging symptoms and easily manageable in patients with a mild-moderate intensity of COVID-19. Our results were not enough to make a correlation between pain and the clinical course of the disease. Further studies are required for the evaluation of pain including patients in intensive care units.
AU  - Deveci, Aydın
AU  - TANYEL, Esra
AU  - kurcaloglu, mustafa
AU  - ketenci, sertaç
AU  - BİLEK, Heval Can
AU  - GÜLDOĞUŞ, Fuat
AU  - ERBAŞ, Sümeyra Nur
AU  - ÖZKAN, Fatih
DO  - 10.14744/agri.2021.92609
PY  - 2021
JO  - Ağrı
VL  - 33
IS  - 4
SN  - 1300-0012
SP  - 215
EP  - 222
DB  - TRDizin
UR  - http://search/yayin/detay/480455
ER  -